Parkside Financial Bank & Trust’s Medtronic MDT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $617K | Sell |
7,119
-446
| -6% | -$42.7K | 0.05% | 225 |
|
|
2025
Q4 | $727K | Buy |
7,565
+643
| +9% | +$62.5K | 0.05% | 202 |
|
|
2025
Q3 | $659K | Sell |
6,922
-467
| -6% | -$42.9K | 0.05% | 205 |
|
|
2025
Q2 | $644K | Buy |
7,389
+495
| +7% | +$42K | 0.07% | 206 |
|
|
2025
Q1 | $619K | Buy |
6,894
+422
| +7% | +$37.8K | 0.08% | 184 |
|
|
2024
Q4 | $517K | Sell |
6,472
-59
| -0.9% | -$5.11K | 0.07% | 200 |
|
|
2024
Q3 | $588K | Buy |
6,531
+74
| +1% | +$6.22K | 0.08% | 175 |
|
|
2024
Q2 | $508K | Sell |
6,457
-542
| -8% | -$44.4K | 0.08% | 180 |
|
|
2024
Q1 | $610K | Buy |
6,999
+722
| +12% | +$61.6K | 0.1% | 164 |
|
|
2023
Q4 | $517K | Buy |
6,277
+328
| +6% | +$25K | 0.09% | 169 |
|
|
2023
Q3 | $466K | Buy |
5,949
+86
| +1% | +$7.2K | 0.11% | 145 |
|
|
2023
Q2 | $517K | Sell |
5,863
-745
| -11% | -$64.1K | 0.12% | 134 |
|
|
2023
Q1 | $533K | Buy |
6,608
+374
| +6% | +$30.5K | 0.14% | 124 |
|
|
2022
Q4 | $485K | Sell |
6,234
-520
| -8% | -$42.1K | 0.14% | 120 |
|
|
2022
Q3 | $545K | Buy |
6,754
+670
| +11% | +$60.2K | 0.17% | 101 |
|
|
2022
Q2 | $547K | Sell |
6,084
-34
| -0.6% | -$3.44K | 0.17% | 110 |
|
|
2022
Q1 | $679K | Sell |
6,118
-170
| -3% | -$18K | 0.18% | 88 |
|
|
2021
Q4 | $650K | Buy |
6,288
+1,481
| +31% | +$171K | 0.16% | 102 |
|
|
2021
Q3 | $603K | Buy |
4,807
+493
| +11% | +$63.8K | 0.18% | 85 |
|
|
2021
Q2 | $535K | Buy |
4,314
+120
| +3% | +$15.1K | 0.15% | 95 |
|
|
2021
Q1 | $495K | Sell |
4,194
-85
| -2% | -$9.96K | 0.15% | 102 |
|
|
2020
Q4 | $501K | Buy |
4,279
+214
| +5% | +$23.6K | 0.16% | 94 |
|
|
2020
Q3 | $422K | Buy |
4,065
+639
| +19% | +$64.2K | 0.15% | 98 |
|
|
2020
Q2 | $314K | Buy |
3,426
+273
| +9% | +$26.2K | 0.1% | 143 |
|
|
2020
Q1 | $284K | Buy |
3,153
+1,579
| +100% | +$168K | 0.11% | 140 |
|
|
2019
Q4 | $178K | Buy |
1,574
+118
| +8% | +$12.9K | 0.05% | 202 |
|
|
2019
Q3 | $158K | Sell |
1,456
-32
| -2% | -$3.34K | 0.05% | 208 |
|
|
2019
Q2 | $145K | Buy |
1,488
+56
| +4% | +$5.11K | 0.05% | 221 |
|
|
2019
Q1 | $131K | Buy |
1,432
+128
| +10% | +$11.5K | 0.04% | 222 |
|
|
2018
Q4 | $119K | Buy |
1,304
+139
| +12% | +$13K | 0.04% | 227 |
|
|
2018
Q3 | $114K | Sell |
1,165
-32
| -3% | -$2.96K | 0.04% | 238 |
|
|
2018
Q2 | $102K | Buy |
1,197
+280
| +31% | +$23.4K | 0.04% | 240 |
|
|
2018
Q1 | $74K | Buy |
917
+76
| +9% | +$6.27K | 0.03% | 281 |
|
|
2017
Q4 | $68K | Sell |
841
-319
| -28% | -$25.5K | 0.02% | 299 |
|
|
2017
Q3 | $91K | Buy |
1,160
+14
| +1% | +$1.16K | 0.04% | 237 |
|
|
2017
Q2 | $102K | Buy |
1,146
+210
| +22% | +$17.7K | 0.04% | 207 |
|
|
2017
Q1 | $76K | Buy |
936
+23
| +3% | +$1.8K | 0.03% | 252 |
|
|
2016
Q4 | $65K | Sell |
913
-1,192
| -57% | -$93.6K | 0.03% | 293 |
|
|
2016
Q3 | $182K | Buy |
2,105
+30
| +1% | +$2.61K | 0.08% | 166 |
|
|
2016
Q2 | $180K | Sell |
2,075
-120
| -5% | -$9.7K | 0.09% | 155 |
|
|
2016
Q1 | $165K | Buy |
2,195
+47
| +2% | +$3.54K | 0.08% | 164 |
|
|
2015
Q4 | $165K | Buy |
2,148
+80
| +4% | +$6.02K | 0.08% | 158 |
|
|
2015
Q3 | $139K | Sell |
2,068
-2,407
| -54% | -$177K | 0.08% | 166 |
|
|
2015
Q2 | $332K | Sell |
4,475
-152
| -3% | -$11.6K | 0.18% | 111 |
|
|
2015
Q1 | $361K | Buy |
4,627
+518
| +13% | +$39.3K | 0.19% | 109 |
|
|
2014
Q4 | $297K | Buy |
4,109
+147
| +4% | +$10.2K | 0.17% | 117 |
|
|
2014
Q3 | $246K | Buy |
+3,962
| New | +$252K | 0.15% | 139 |
|
Other funds holding MDT
VCM
VPM
Parkside Financial Bank & Trust's MDT Position: Q1 2026 in Review
Parkside Financial Bank & Trust reduced its Medtronic (MDT) stake by 5.9% in Q1 2026, selling an estimated $42.7K and leaving 7,119 shares worth $617K. The position accounts for 0.05% of the portfolio, ranked #225.
Parkside Financial Bank & Trust first reported a position in MDT in Q3 2014 and has held it in 47 quarters since. The position peaked at $727K in Q4 2025. 2,229 funds tracked by Wall St. Rank hold MDT as of Q1 2026.
- Parkside Financial Bank & Trust held 7,119 shares of Medtronic worth $617K as of Q1 2026.
- Parkside Financial Bank & Trust sold 446 Medtronic shares in Q1 2026, an estimated $42.7K.
- Medtronic made up 0.05% of Parkside Financial Bank & Trust's portfolio in Q1 2026, its #225 holding.
- Parkside Financial Bank & Trust first reported a position in Medtronic in Q3 2014 and has held it in 47 quarters since.
- Parkside Financial Bank & Trust's Medtronic position peaked at $727K in Q4 2025.
- 2,229 funds tracked by Wall St. Rank held Medtronic as of Q1 2026.
Based on Parkside Financial Bank & Trust's 13F filing for Q1 2026, filed 13 May 2026.